BIOA BioAge Labs posts narrower Q4 2025 loss than expected shares fall 11 percent today PAYC Paycom Software falls 142 as Q4 2025 EPS narrowly comes in below analyst consensus estimates Vertex Pharmaceuticals Incorporated VRTX Casgevy Commercial Momentum and Pipeline Catalysts Signal Upside Ahead of Partner CRISPR Therapeutics Q1 2026 Earnings